Jerrold David Cantor

Consolidated Medical Bioanalysis (CMB) has been a leader in diagnostic technologies since 1979, focused on improving patient care through a comprehensive range of clinical assays, including routine blood analyses, HIV testing, and genomic testing. The organization blends a full-service clinical laboratory with a clinical trials research group, dedicated to advancing healthcare solutions in partnership with physicians and pharmaceutical companies. CMB prides itself on delivering high-quality service while fostering a culture of innovation and personalized care, which has resulted in exceptional client satisfaction. Their commitment to enhancing patient services is exemplified by the upcoming launch of new web portals for providers and patients, aimed at streamlining access to critical health information. Generated from the website